A previous single fasting plasma glucose concentration measured
within 6 months prior to the OGTT in the same hospital laboratory,
was available for 187 of the included women for evaluation of the robustness
of our proposed method of step-wise screening for diabetes in
PCOS patients. First, we evaluated the OGTT outcome of those
women who would be selected for OGTT screening based on the previous
FG concentration.